In the Media

November 1, 2018

Video: InMed CEO Eric A. Adams – how InMed is different from competitors

In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.

InMed does not grow cannabis. We biosynthesize the compounds in a lab.
InMed products do not contain THC.
InMed products are applied topically.

Source: BTV

Share this post

Latest Media News

Cannabinol 101: The Science of Cannabinol (CBN)

Cannabinol, or CBN for short, is one of the more than 100 rare cannabinoids found in the Cannabis plant. CBN is found in aged Cannabis

June 8, 2020

InMed’s cannabinol (CBN) formulation for glaucoma – Executive Interview with CEO Eric A. Adams

In this video, InMed Pharmaceuticals CEO Eric A. Adams speaks about the company’s ocular disease program. INM-088 is a cannabinol (CBN) formulation showing potential to

May 27, 2020

InMed’s therapeutic development of cannabinol and update on programs – Executive Interview with CEO Eric A. Adams

In this video, InMed Pharmaceuticals’ CEO Eric A. Adams speaks about the company’s therapeutic development of cannabinol (CBN), a rare cannabinoid showing potential to treat

May 11, 2020